Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Shared cerebral metabolic pathology in non-transgenic animal models of Alzheimer's and Parkinson's disease
Jelena Osmanović Barilar, Ana Knezović, Ana Babić Perhoč, et al.
Journal of Neural Transmission (2020) Vol. 127, Iss. 2, pp. 231-250
Open Access | Times Cited: 18

Showing 18 citing articles:

Brain insulin resistance: role in neurodegenerative disease and potential for targeting
Christian Hölscher
Expert Opinion on Investigational Drugs (2020) Vol. 29, Iss. 4, pp. 333-348
Open Access | Times Cited: 137
NF‐κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective
Mohammed Alrouji, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 13, pp. 1775-1789
Open Access | Times Cited: 33
Promising use of metformin in treating neurological disorders: biomarker-guided therapies
Allison Loan, Charvi Syal, Margarita Lui, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 5, pp. 1045-1055
Open Access | Times Cited: 18
The Absence of Gastrointestinal Redox Dyshomeostasis in the Brain-First Rat Model of Parkinson’s Disease Induced by Bilateral Intrastriatal 6-Hydroxydopamine
Jan Homolak, Mihovil Joja, Gracia Grabarić, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 8, pp. 5481-5493
Open Access | Times Cited: 5
Toxic interactions between dopamine, α-synuclein, monoamine oxidase, and genes in mitochondria of Parkinson’s disease
Makoto Naoi, Wakako Maruyama, Masayo Shamoto‐Nagai, et al.
Journal of Neural Transmission (2024) Vol. 131, Iss. 6, pp. 639-661
Closed Access | Times Cited: 5
Challenges of repurposing tetracyclines for the treatment of Alzheimer’s and Parkinson’s disease
Iva Markulin, Marija Matašin, Viktorija Erdeljić Turk, et al.
Journal of Neural Transmission (2022) Vol. 129, Iss. 5-6, pp. 773-804
Closed Access | Times Cited: 21
Disbalance of the Duodenal Epithelial Cell Turnover and Apoptosis Accompanies Insensitivity of Intestinal Redox Homeostasis to Inhibition of the Brain Glucose-Dependent Insulinotropic Polypeptide Receptors in a Rat Model of Sporadic Alzheimer’s Disease
Jan Homolak, Ana Babić Perhoč, Ana Knezović, et al.
Neuroendocrinology (2021) Vol. 112, Iss. 8, pp. 744-762
Closed Access | Times Cited: 21
Effect of amylin on memory and central insulin resistance in a rat model of Alzheimer’s disease
Seham Zakaria Nassar, Noha Mohamed Badae, Yasmine Amr Issa
Archives of Physiology and Biochemistry (2018) Vol. 126, Iss. 4, pp. 326-334
Closed Access | Times Cited: 23
Gastrointestinal Non-Motor Dysfunction in Parkinson’s Disease Model Rats with 6-hydroxydopamine
Xiao‐Yan Feng, Jingting Yan, Xiaoli Zhang, et al.
Physiological Research (2019), pp. 295-303
Open Access | Times Cited: 21
Additional methodological considerations regarding optimization of the dose of intracerebroventricular streptozotocin A response to: “Optimization of intracerebroventricular streptozotocin dose for the induction of neuroinflammation and memory impairments in rats” by Ghosh et al., Metab Brain Dis 2020 July 21
Jan Homolak, Ana Babić Perhoč, Ana Knezović, et al.
Metabolic Brain Disease (2020) Vol. 36, Iss. 1, pp. 97-102
Closed Access | Times Cited: 16
Association of Cognitive Deficit with Glutamate and Insulin Signaling in a Rat Model of Parkinson’s Disease
Ana Knezović, Marija Piknjac, Jelena Osmanović Barilar, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 683-683
Open Access | Times Cited: 5
The absence of gastrointestinal redox dyshomeostasis in the brain-first rat model of Parkinson’s disease induced by bilateral intrastriatal 6-hydroxydopamine
Jan Homolak, Mihovil Joja, Gracia Grabarić, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 7
MODELING OF PARKINSON'S DISEASE BY INTRASTRIATAL ADMINISTRATION OF STREPTOZOTOCIN
Jelena Osmanović Barilar, Vladimir Papić, Vladimir Farkaš, et al.
Neuropharmacology (2024) Vol. 265, pp. 110246-110246
Closed Access | Times Cited: 1
Circadian changes in Alzheimer's disease: Neurobiology, clinical problems, and therapeutic opportunities
Karlo Toljan, Jan Homolak
Handbook of clinical neurology (2021), pp. 285-300
Closed Access | Times Cited: 8
Association of Cognitive Deficit with Glutamate and Insulin Signaling in a Rat Model of Parkinson's Disease
Ana Knezović, Marija Piknjac, Jelena Osmanović Barilar, et al.
(2023)
Open Access | Times Cited: 1
Disbalance of the intestinal epithelial cell turnover and apoptosis in a rat model of sporadic Alzheimer’s disease
Jan Homolak, Ana Babić Perhoč, Ana Knezović, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 2
Emerging role of metabolomics in protein conformational disorders
Nimisha Gupta, Sreelakshmi Ramakrishnan, Saima Wajid
Expert Review of Proteomics (2021) Vol. 18, Iss. 5, pp. 395-410
Closed Access | Times Cited: 1
Diabetes as a risk factor for neurodegenerative diseases
Laura Tomić
(2020)
Closed Access
Page 1

Scroll to top